{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "go:GO:0007155",
      "entity_text" : "adhesion",
      "entity_type" : "bioprocess"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:44795",
      "entity_text" : "ATRA",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : true
  },
  "verbose_text" : "In addition, ATRA distributes to the CNS only at low concentrations and may explain the high frequency of CNS involvement.5 An ex vivo experiment showed that ATRA increases adhesion molecules in leukemic cells, indicating the possibility of enhancing migration and adhesion to extramedullary tissues.6 However, a large cohort study demonstrated no increased risk of developing EMD for ATRA based therapy compared to chemotherapy alone.7 Because EMD usually occurs in the relapse phase and many CNS cases are included, survival after developing EMD is poor.",
  "reading_complete" : "2020-08-03T15:43:12Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T15:42:40Z",
  "trigger" : "increases",
  "evidence" : [ "ATRA increases adhesion" ],
  "pmc_id" : "6389481",
  "score" : 0
}